TAURITMO Trademark

Trademark Overview

On Wednesday, October 1, 2008, a trademark application was filed for TAURITMO with the United States Patent and Trademark Office. The USPTO has given the TAURITMO trademark a serial number of 79059980. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, October 1, 2018. This trademark is owned by NOVARTIS AG. The TAURITMO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genito-urinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, haematology and in tissues and organ transplantation, in ophthalmology, and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; for the treatment of bacteria-based diseases; for the treatment of diabetes, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations
tauritmo

General Information

Serial Number79059980
Word MarkTAURITMO
Filing DateWednesday, October 1, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, October 1, 2018
Registration Number3639870
Registration DateTuesday, June 16, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 31, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genito-urinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, haematology and in tissues and organ transplantation, in ophthalmology, and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; for the treatment of bacteria-based diseases; for the treatment of diabetes, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, October 26, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Monday, May 6, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, May 6, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, November 18, 2016NOTIFICATION PROCESSED BY IB
Monday, November 16, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, November 15, 2015DEATH OF INTERNATIONAL REGISTRATION
Monday, April 15, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, April 13, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, September 25, 2009FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 25, 2009FINAL DISPOSITION PROCESSED
Thursday, September 17, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, June 27, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, June 27, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 16, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, March 31, 2009PUBLISHED FOR OPPOSITION
Wednesday, March 11, 2009NOTICE OF PUBLICATION
Friday, February 20, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 20, 2009ASSIGNED TO LIE
Thursday, February 12, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 12, 2009EXAMINER'S AMENDMENT ENTERED
Thursday, February 12, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 12, 2009EXAMINERS AMENDMENT E-MAILED
Thursday, February 12, 2009EXAMINERS AMENDMENT -WRITTEN
Thursday, February 5, 2009REFUSAL PROCESSED BY IB
Monday, February 2, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 2, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 16, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, December 16, 2008REFUSAL PROCESSED BY MPU
Monday, December 15, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, December 14, 2008NON-FINAL ACTION WRITTEN
Wednesday, December 3, 2008ASSIGNED TO EXAMINER
Friday, November 14, 2008APPLICATION FILING RECEIPT MAILED
Monday, November 10, 2008NEW APPLICATION ENTERED IN TRAM
Friday, November 7, 2008LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Thursday, November 6, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

tauritmo system preparations treatment disorders pharmaceutical prevention diseases ocular gastroenterological transplantation